Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice

International Immunopharmacology

Volumn 1, Issue 2, 2001, Pages 189-199

  Hartmann, Georgy ^a   Kim, Hani ^a   Piquette Miller, Micheline ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cytokines; Gene expression; Inflammation; Liver; Multidrug resistance; P glycoprotein

Indexed keywords

CYTOKINE; ENDOTOXIN; GLYCOPROTEIN P; INTERLEUKIN 1BETA; INTERLEUKIN 6; MULTIDRUG RESISTANCE PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TURPENTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; INFLAMMATION; LIVER; MEMBRANE TRANSPORT; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CYTOKINES; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; P-GLYCOPROTEIN; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035115303     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)00271-X     Document Type: Article

References (28)

1. Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies
2. Methods to detect PGP associated multidrug resistance in patient's tumors: Concensus recommendation
3. Genetic dissection of the function of mammalian P-glycoproteins
4. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues
5. The biochemistry of P-glycoprotein-mediated multidrug resistance
6. The inflammatory response in interleukin-1beta-deficient mice: Comparison with other cytokine-related knockout mice
7. Defective inflammatory response in interleukin-6-deficient mice
8. Cytokines and acute phase protein expression
9. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies
10. MDR1 gene expression in solid tumors
11. Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphatase activity
12. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents
13. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies
14. Multidrug resistance: Molecular mechanisms and clinical relevance
15. Regulation of cytochromes P450 during inflammation and infection
16. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation
17. Interleukin-1 and interleukin-6 stimulate acute-phase protein production in primary mouse hepatocytes
18. Interleukin-6, the third mediator of acute-phase protein reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukinbeta and tumor necrosis factor-alpha
19. Interleukindepresses cytochrome P450 levels and activities in mice
20. Interleukin-6 decreases P-glycoprotein expression in cultured rat hepatocytes
21. Regulation of cytochrome P450 IID by acute phase mediators in C3H/H3J mice
22. Effect of colchicine and heat shock on multidrug resistance gene and P-glycoprotein expression in rat liver
23. Upregulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver
24. Influence of cytokines and mdr1 expression in human colon carcinoma cells: Increased cytotoxicity of MDR relevant drugs
25. Acute phase proteins
26. Tumor necrosis factor-alpha decreases hepatocyte bile salt and mediates endotoxin-induced cholestasis